Cargando…
I-SPY 2: optimising cancer drug development in the 21st century
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115814/ https://www.ncbi.nlm.nih.gov/pubmed/27900209 http://dx.doi.org/10.1136/esmoopen-2016-000113 |
_version_ | 1782468576071909376 |
---|---|
author | Bartsch, Rupert de Azambuja, Evandro |
author_facet | Bartsch, Rupert de Azambuja, Evandro |
author_sort | Bartsch, Rupert |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5115814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51158142016-11-29 I-SPY 2: optimising cancer drug development in the 21st century Bartsch, Rupert de Azambuja, Evandro ESMO Open Editorial BMJ Publishing Group 2016-11-15 /pmc/articles/PMC5115814/ /pubmed/27900209 http://dx.doi.org/10.1136/esmoopen-2016-000113 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Editorial Bartsch, Rupert de Azambuja, Evandro I-SPY 2: optimising cancer drug development in the 21st century |
title | I-SPY 2: optimising cancer drug development in the 21st century |
title_full | I-SPY 2: optimising cancer drug development in the 21st century |
title_fullStr | I-SPY 2: optimising cancer drug development in the 21st century |
title_full_unstemmed | I-SPY 2: optimising cancer drug development in the 21st century |
title_short | I-SPY 2: optimising cancer drug development in the 21st century |
title_sort | i-spy 2: optimising cancer drug development in the 21st century |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115814/ https://www.ncbi.nlm.nih.gov/pubmed/27900209 http://dx.doi.org/10.1136/esmoopen-2016-000113 |
work_keys_str_mv | AT bartschrupert ispy2optimisingcancerdrugdevelopmentinthe21stcentury AT deazambujaevandro ispy2optimisingcancerdrugdevelopmentinthe21stcentury |